“To determine whether adjunctive dronabinol, a licensed form of delta-9-tetrahydrocannabinol, reduces opioid consumption when used off-label for managing acute pain following traumatic injury.
CONCLUSIONS:
The results of this study suggest adjunctive dronabinol reduces opioid consumption following traumatic injury.
The opioid-sparing effect of dronabinol may be greater in patients who are marijuana users.”